Simbrinza, a combination medication containing brinzolamide and brimonidine, was previously prescribed to lower intraocular pressure in patients with open-angle glaucoma or ocular hypertension. Discontinuation refers to the cessation of its production and availability, preventing future prescriptions or refills.
Pharmaceutical medications are removed from the market for a variety of reasons. Often, a manufacturer’s decision to discontinue a drug stems from economic considerations. This may include factors such as low sales volume, the availability of more cost-effective alternative treatments, or changes in a company’s strategic priorities. Scarcity of raw materials needed for production or manufacturing difficulties can also lead to a discontinuation. In some instances, regulatory concerns or newly discovered safety issues, although less common, may contribute to this decision.
